Annually, urinary tract infections (UTI) are responsible for more than 11 million physician visits in the United States. Although normally a commensal inhabitant of the intestinal and gastrointestinal tract of humans,Escherichia coliis the most common urinary-tract pathogen, whose overgrowth and over colonization accounts for 85% of UTI. Cranberries have been used as a medicinal agent for centuries to promote health, but recently the scientific literature has proven that proanthocyanidins, contained in cranberries, as well as a simple sugar, ᴅ‑mannose, specifically inhibit the adhesion and proliferation ofE. coliin the urinary tract. Cranberry extracts and ᴅ‑mannose each independently inhibit one of two adhesion methods utilized byE. coli. Combined together in a synergistic and novel formula,D‑Mannose SAPaddresses both type-1 (FimH) and P-type fimbrial-mediated adhesion byE. colito the urinary tract mucosa.D‑Mannose SAPis specifically targeted for the treatment and prevention ofE. coliUTI.
Ingredients
Each 5 g (approx. 2 1/2 teaspoons) contains:
Cranberry (Vaccinium macrocarpon)
400 mg
ᴅ‑Mannose
4600 mg
Contains no
Gluten, soy, wheat, eggs, dairy, yeast, citrus, preservatives, artificial flavour or colour, starch, or sugar.
Directions for use
Adults: Take 5 g (approx. 2 1/2 teaspoons) once or twice daily or as directed by your healthcare practitioner.